Author:
Alloatti Giuseppe,Gallo Maria Pia
Publisher
Springer International Publishing
Reference72 articles.
1. Alloatti G, Penna C, De Martino A, Montrucchio G, Camussi G (1999) Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. Cardiovasc Res 41:611–619
2. Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK et al (2008) The antihypertensive chromogranin A peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 149:4780–4793
3. Angelone T, Quintieri AM, Goumon Y, Di Felice V, Filice E, Gattuso A et al (2010) Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA(1-64)) in the rat heart. Regul Pept 165:78–85
4. Angelone T, Mazza R, Cerra MC (2012a) Chromogranin-A: a multifaceted cardiovascular role in health and disease. Curr Med Chem 19:4042–4050
5. Angelone T, Quintieri AM, Pasqua T, Gentile S, Tota B, Mahata SK et al (2012b) Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin. Am J Phys Heart Circ Phys 302:H431–H442